HR Execs on the Move

Invitae

www.invitae.com

 
Invitae is a leader in medical genetic testing, driving genetic information into mainstream medicine to improve healthcare for billions of people. Invitae is aggregating the world`s medical genetic tests into a single service with higher quality, faster turnaround time, and lower prices. By driving down the cost of genetic testing we make it affordable and accessible to everyone who can benefit. Why medical genetics? Within each of us lies information coded in our DNA that can transform our health. Unlocking those answers to make medicine more personalized requires highly specialized, multidisciplinary collaboration. Our platform is setting the standard for the ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.invitae.com
  • 1400, 16th Street
    San Francisco, CA USA 94103
  • Phone: 415.374.7782

Executives

Name Title Contact Details
Ana Schrank
Chief Financial Officer Profile
Robert Dickey
Interim Chief Financial Officer Profile
Robert Dickey
Interim Chief Financial Officer Profile
Matt Willmon
Vice President, Total Rewards Profile
Eric Olivares
Head of Research And Development Profile

Similar Companies

Neurogene

Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families.

ChemNavigator

ChemNavigator is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Puerto Rico Labor and Human Resources

Puerto Rico Labor and Human Resources is a New York, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Psyadon Pharmaceuticals

Psyadon Pharmaceuticals is a Germantown, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Prevail Therapeutics

At Prevail Therapeutics, we are pioneering innovative therapies that aim to cure neurodegenerative disorders, such as Parkinson`s disease. Our mission is to translate breakthrough advances in human genetics and gene therapy technology into life-changing medicines that slow, stop and reverse the neurodegenerative process. Our novel gene therapies target patients with urgent unmet needs, where there are currently no available therapies to change the progressive course of their diseases. Prevail was formed in 2017, and as an emerging biotechnology company, we are growing rapidly. We are building a team of dedicated, creative and talented individuals who share our passion for serving patients with neurodegenerative diseases. We pride ourselves on following great science, and we value collaboration, integrity and agility. We are based in the Alexandria Center for Life Science in New York City.